Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access December 6, 2013

Effect of ginkgo extract on eye microcirculation in patients with diabetes

Asta Spadiene, Nijole Savickiene, Nijole Jurgeviciene, Rimantas Zalinkevicius, Antanas Norkus, Rytas Ostrauskas, Andrejs Skesters, Alisa Silova, Hiliaras Rodovicius and Miglė Francaite-Daugeliene
From the journal Open Medicine


The prevalence of Diabetes mellitus has increased around the world in the last decade. Anyone with diabetes is at risk of diabetic eye complications. The aim of the study was to compare effects of standardized Ginkgo biloba (Ginkgo biloba L.) dry extract (Ex.Gb) with the placebo on the microcirculation lesions of the eye in randomized double-blind placebo-controlled trial. 44 patients with type 2 diabetes mellitus were randomized to Ex.Gb 160 mg per day or placebo, and were followed up for nine months. Dose of Ex.Gb was increased to 240 mg in next nine months. Total Antioxidant Status (TAS) of plasma was measured using the Trolox equivalent antioxidant capacity assay. Ophthalmologic examination was performed by the biomicroscopic method. Vascular, intravascular and perivascular alterations were evaluated, and total conjunctival index was calculated. Though the values of the total conjunctival index and its constituent decreased (P<0.05) during the study in Ex.Gb group, there were no significant differences between these parameters as compared with placebo group. Evaluation of plasma TAS showed gradually increment, although insignificant and very small, in Ex.Gb group. The significance of Ex.Gb on development of the alterations of eye microcirculation, especially in elder patients needs to be explored further.

[1] International Diabetes Federation, One adult in ten will have diabetes by 2030, Press Release — World Diabetes Day, Brussels 2011, Search in Google Scholar

[2] International Diabetes Federation, Europe’s children top the global diabetes stakes, Press Release — World Diabetes Day, Brussels 2011, Search in Google Scholar

[3] Kowluru R.A., Chan P.S., Oxidative Stress and Diabetic Retinopathy, Exp. Diabetes Res. 2007, 2007:43603 10.1155/2007/43603Search in Google Scholar PubMed PubMed Central

[4] International Diabetes Federation, Fact sheet: Diabetes and eye disease, 2011, Search in Google Scholar

[5] Fowler M.J., Microvascular and Macrovascular Complications of Diabetes, Clin. Diabetes, 2008, 26(2), 77–88 in Google Scholar

[6] Moricke R., Die Beurteilung degenerativer Gefassprozesse an der terminalen Strombahn der Conjuctiva bulbi mit einem Konjunktival index. Innere Medizin, Leipzig, 1973, 2, 32–36 (in German) Search in Google Scholar

[7] Miniauskiene G., Jasinskas V., Association of metabolic syndrome with abnormalities of bulbar conjunctival vessels, Medicina, 2008, 44(2), 100–109 10.3390/medicina44020013Search in Google Scholar

[8] Danilova Al., Microcirculatory disorder in the bulbar conjunctiva of patients with diabetic retinopathy, Probl Endokrinol (Mosk), 1986, 32(5), 18–22 Search in Google Scholar

[9] Baynes J.W., Thorpe S.R., Role of Oxidative Stress in Diabetic Complications: A New Perspective on an Old Paradigm, Diabetes, 1999, 48(1), 1–9 in Google Scholar PubMed

[10] Bashan N., Kovsan J., Kachko I., Ovadia H., Rudich A., Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species, Physiol Rev., 2009, 89(1), 27–71 in Google Scholar PubMed

[11] Jay D., Hitomi H., Griendling K.K., Oxidative stress and diabetic cardiovascular complications, Free Radic. Biol. Med., 2006, 40(2), 183–192 in Google Scholar PubMed

[12] Pitocco D., Zaccardi F., Stasio E., Romitelli F., Santini S.A., Zuppi C., et al., Oxidative Stress, Nitric Oxide, and Diabetes, Rev. Diabet. Stud., 2010, 7(1), 15–25 in Google Scholar PubMed PubMed Central

[13] Fong D.S., Aiello L.P., Ferris F.L., Klein R., Diabetic Retinopathy, Diabetes Care, 2004, 27(10), 2540–2553 in Google Scholar PubMed

[14] Giacco F., Brownlee M., Oxidative stress and diabetic complications, Circ. Res., 2010, 107(9), 1058–1070 in Google Scholar PubMed PubMed Central

[15] E/S/C/O/P Monographs, The Scientific Foundation for Herbal Medicinal Products, 2003, pp.178–210 Search in Google Scholar

[16] Barnes J., Anderson L.A., Phillipson J.D., Herbal Medicines Second edition. Pharmaceutical Press, 2002, pp. 250–263. Search in Google Scholar

[17] Rahman K., Studies on free radicals, antioxidants, and co-factors, Clin. Interv. Aging., 2007, 2(2), 219–236 Search in Google Scholar

[18] Stefek M., Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract, Interdiscip. Toxicol., 2011, 4(2), 69–77 10.2478/v10102-011-0013-ySearch in Google Scholar PubMed PubMed Central

[19] Kudolo G.B., Delaney D., Blodgett J., Short-term oral ingestion of Ginkgo biloba extract (EGb 761) reduces malondialdehyde levels in washed platelets of type 2 diabetic subjects, Diabetes Res. Clin. Pract., 2005, 68, 29–38 in Google Scholar

[20] Nijveldt R.J., Nood E., Hoorn D.E.C., Boelens P.G., Norren K., Leeuwen, P.A.M., Flavonoids: a review of probable mechanisms of action and potential applications, Am. J. Clin. Nutr., 2001, 74(4), 418–425. 10.1093/ajcn/74.4.418Search in Google Scholar

[21] Ferrali M., Signorini C., Caciotti B., Sugherini L., Ciccoli L., Giachetti D.,, Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity, FEBS Lett., 1997, 416, 123–129 in Google Scholar

[22] Ritch R., Potential role for Ginkgo biloba extract in the treatment of glaucoma, Med. Hypotheses., 2000, 54(2), 221–235 in Google Scholar PubMed

[23] Cybulska-Heinrich A.K., Mozaffarieh M., Flammer J., Ginkgo biloba: An adjuvant therapy for progressive normal and high tension glaucoma, Mol. Vis., 2012, 18, 390–402 Search in Google Scholar

[24] Kudolo G.B., The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic beta-cell function in response to glucose loading in normal glucose tolerant individuals, J. Clin. Pharmacol., 2000, 40, 647–654 in Google Scholar

[25] Lanthony P., Cosson J.P., The course of color vision in early diabetic retinopathy treated with ginkgo biloba extract. A preliminary, double-blind versus placebo study, J. Fr. Ophtalmol., 1988, 11, 71–674 Search in Google Scholar

[26] Chung H.S., Harris A., Kristinsson J.K., Ciulla T.A., Kagemann C., Ritch, R., Ginkgo biloba extract increases ocular blood flow velocity, J. Ocul. Pharmacol. Ther., 1999, 15, 233–240 in Google Scholar PubMed

[27] Lee D.J., Ahn H.B., Rho S.H., The effect of Ginkgo biloba to retinal microcirculation, J. Korean Ophthalmol. Soc., 2002, 43, 1522–1527 Search in Google Scholar

[28] Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., Milner A., A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates, Clin. Sci., 1993, 84, 407–412 10.1042/cs0840407Search in Google Scholar PubMed

Published Online: 2013-12-6
Published in Print: 2013-12-1

© 2013 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Scroll Up Arrow